TRIUMF welcomed Prime Minister Trudeau for a special visit where he announced investments to support a new state-of-the art life sciences facility, the Institute for Advanced Medical Isotopes (IAMI)
Designed to maximize impact, build on existing strengths, and capitalize on emerging opportunities, TRIUMF’s Five-Year Plan 2020-2025 lays out a vision for Canada’s particle accelerator centre for the next five years and the decades beyond
Neutrino physics researchers at TRIUMF and around the world welcome new signals of support for planned Hyper-K detector
Vancouver photographer’s striking image selected from thousands of images submitted by hundreds of amateur and professional photographers around the world
Leading Canadian laboratories collaborate to produce Actinium-225, a rare medical isotope with the potential to revolutionize the fight against untreatable forms of cancer
A new short documentary, The Rarest Drug on Earth, is delving into the possibility for TRIUMF to take up the reins as the world’s largest producer of actinium-225.
With a Mitacs award win under his belt, TRIUMF graduate student, Vanier scholar, and UBC Ph.D. candidate Sébastien Rettie is embarking for the Weizmann Institute of Science to work on upgrades for ATLAS' New Muon Small Wheels system.
With help from TRIUMF scientists, the ALPHA experiment at CERN has for the first time observed a benchmark atomic energy transition in antihydrogen
Beauty may be in the eye of the beholder, but a detector array in the hand of a skilled photographer took first-place in the 2018 TRIUMF Photowalk.
TRIUMF Science Week 2018 brought to light nearly every aspect of the lab’s rich and diverse science programming.